Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7061-7070 of 12127

Page
per page
  1. trans-Sulfo-SMCC
    BA2574 trans-Sulfo-SMCC
    Summary: A non-cleavable membrane permeable ADC crosslinker.
  2. CP681301
    BA3799 CP681301
    Summary: CP681301 is an effective inhibitor.
  3. Fmoc-D-Nle-OH
    BA9329 Fmoc-D-Nle-OH
    Summary: A leucine derivative.
  4. AG 1406
    C8473 AG 1406
      ≥50 mg/mL
  5. Indisulam
    BA7206 Indisulam
    Summary: Indisulam (E7070) is an inhibitor with anticancer activity.
      ≥40.5 mg/mL
  6. Butyryl carnitine-d3 HCl
    SL1029 Butyryl carnitine-d3 HCl
    Summary: A stable isotope deuterated compound of Butyryl carnitine HCl
  7. NCH 51
    A4495 NCH 51
    Summary: Histone deacetylase (HDAC) inhibitor
  8. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  9. Sunitinib malate
    A8255 Sunitinib malate
     5 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  10. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     3 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL

Items 7061-7070 of 12127

Page
per page